Joint statement on diabetes treatment

ANZCA has published a joint statment with diabetes groups in Australia and NZ on periprocedural diabetic ketoacidosis and SGLT2i use.
 
The statement outlines a number of key considerations and suggested management strategies when seeing patients who are taking SGLT2i medication. To read the joint statement please see here.
Copyright © Australian and New Zealand College of Anaesthetists.